Cargando…

NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression

Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease with a high lethality rate in infants. Variants in the homologous genes survival of motor neuron (SMN)1 and SMN2 have been reported to be SMA pathogenic factors. Previous studies showed that a high inclusion rate of SMN2 exon 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Li-Li, Sun, Jun-Jie, Chen, Zhi-Heng, Shao, Yi-Xiang, Wu, Liu-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120702/
https://www.ncbi.nlm.nih.gov/pubmed/35535907
http://dx.doi.org/10.4103/1673-5374.339005
_version_ 1784710989127614464
author Du, Li-Li
Sun, Jun-Jie
Chen, Zhi-Heng
Shao, Yi-Xiang
Wu, Liu-Cheng
author_facet Du, Li-Li
Sun, Jun-Jie
Chen, Zhi-Heng
Shao, Yi-Xiang
Wu, Liu-Cheng
author_sort Du, Li-Li
collection PubMed
description Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease with a high lethality rate in infants. Variants in the homologous genes survival of motor neuron (SMN)1 and SMN2 have been reported to be SMA pathogenic factors. Previous studies showed that a high inclusion rate of SMN2 exon 7 increased SMN expression, which in turn reduced the severity of SMA. The inclusion rate of SMN2 exon 7 was higher in neural tissues than in non-neural tissues. Neuro-oncological ventral antigen (NOVA) is a splicing factor that is specifically and highly expressed in neurons. It plays a key role in nervous system development and in the induction of nervous system diseases. However, it remains unclear whether this splicing factor affects SMA. In this study, we analyzed the inclusion of SMN2 exon 7 in different tissues in a mouse model of SMA (genotype smn(–/–)SMN2(2tg/0)) and littermate controls (genotype smn(+/–)SMN2(2tg/0)). We found that inclusion level of SMN2 exon 7 was high in the brain and spinal cord tissue, and that NOVA1 was also highly expressed in nervous system tissues. In addition, SMN2 exon 7 and NOVA1 were expressed synchronously in the central nervous system. We further investigated the effects of NOVA1 on disease and found that the number of neurons in the anterior horn of spinal cord decreased in the mouse model of SMA during postnatal days 1–7, and that NOVA1 expression levels in motor neurons decreased simultaneously as spinal muscular atrophy developed. We also found that in vitro expression of NOVA1 increased the inclusion of SMN2 exon 7 and expression of the SMN2 protein in the U87MG cell line, whereas the opposite was observed when NOVA1 was knocked down. Finally, point mutation and RNA pull-down showed that the UCAC motif in SMN2 exon 7 plays a critical role in NOVA1 binding and promoting the inclusion of exon 7. Moreover, CA was more essential for the inclusion of exon 7 than the order of Y residues in the motif. Collectively, these findings indicate that NOVA1 interacts with the UCAC motif in exon 7 of SMN2, thereby enhancing inclusion of exon 7 in SMN2, which in turn increases expression of the SMN protein.
format Online
Article
Text
id pubmed-9120702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91207022022-05-21 NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression Du, Li-Li Sun, Jun-Jie Chen, Zhi-Heng Shao, Yi-Xiang Wu, Liu-Cheng Neural Regen Res Research Article Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease with a high lethality rate in infants. Variants in the homologous genes survival of motor neuron (SMN)1 and SMN2 have been reported to be SMA pathogenic factors. Previous studies showed that a high inclusion rate of SMN2 exon 7 increased SMN expression, which in turn reduced the severity of SMA. The inclusion rate of SMN2 exon 7 was higher in neural tissues than in non-neural tissues. Neuro-oncological ventral antigen (NOVA) is a splicing factor that is specifically and highly expressed in neurons. It plays a key role in nervous system development and in the induction of nervous system diseases. However, it remains unclear whether this splicing factor affects SMA. In this study, we analyzed the inclusion of SMN2 exon 7 in different tissues in a mouse model of SMA (genotype smn(–/–)SMN2(2tg/0)) and littermate controls (genotype smn(+/–)SMN2(2tg/0)). We found that inclusion level of SMN2 exon 7 was high in the brain and spinal cord tissue, and that NOVA1 was also highly expressed in nervous system tissues. In addition, SMN2 exon 7 and NOVA1 were expressed synchronously in the central nervous system. We further investigated the effects of NOVA1 on disease and found that the number of neurons in the anterior horn of spinal cord decreased in the mouse model of SMA during postnatal days 1–7, and that NOVA1 expression levels in motor neurons decreased simultaneously as spinal muscular atrophy developed. We also found that in vitro expression of NOVA1 increased the inclusion of SMN2 exon 7 and expression of the SMN2 protein in the U87MG cell line, whereas the opposite was observed when NOVA1 was knocked down. Finally, point mutation and RNA pull-down showed that the UCAC motif in SMN2 exon 7 plays a critical role in NOVA1 binding and promoting the inclusion of exon 7. Moreover, CA was more essential for the inclusion of exon 7 than the order of Y residues in the motif. Collectively, these findings indicate that NOVA1 interacts with the UCAC motif in exon 7 of SMN2, thereby enhancing inclusion of exon 7 in SMN2, which in turn increases expression of the SMN protein. Wolters Kluwer - Medknow 2022-04-01 /pmc/articles/PMC9120702/ /pubmed/35535907 http://dx.doi.org/10.4103/1673-5374.339005 Text en Copyright: © Neural Regeneration Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Du, Li-Li
Sun, Jun-Jie
Chen, Zhi-Heng
Shao, Yi-Xiang
Wu, Liu-Cheng
NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title_full NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title_fullStr NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title_full_unstemmed NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title_short NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression
title_sort nova1 promotes smn2 exon 7 splicing by binding the ucac motif and increases smn protein expression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120702/
https://www.ncbi.nlm.nih.gov/pubmed/35535907
http://dx.doi.org/10.4103/1673-5374.339005
work_keys_str_mv AT dulili nova1promotessmn2exon7splicingbybindingtheucacmotifandincreasessmnproteinexpression
AT sunjunjie nova1promotessmn2exon7splicingbybindingtheucacmotifandincreasessmnproteinexpression
AT chenzhiheng nova1promotessmn2exon7splicingbybindingtheucacmotifandincreasessmnproteinexpression
AT shaoyixiang nova1promotessmn2exon7splicingbybindingtheucacmotifandincreasessmnproteinexpression
AT wuliucheng nova1promotessmn2exon7splicingbybindingtheucacmotifandincreasessmnproteinexpression